![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
TJ Rimele, RJ Sturm, LM Adams, DE Henry, RJ Heaslip, BM Weichman and D Grimes
Department of Pharmacology, Ayerst Laboratories Research, Inc., Princeton, New Jersey.
Experiments were designed to study the interaction of rat peritoneal neutrophils with the vascular smooth muscle of the rat aorta. Rings of aorta, suspended in 10-ml organ chambers containing a physiologic salt solution, were precontracted with phenylephrine. Neutrophils (1 X 10(5) -4 X 10(7) cells/organ chamber) caused a cell number-dependent relaxation of the rat aorta that was augmented by superoxide dismutase (100 U/ml) or changing the oxygen content from 95 to 21%. The neutrophil-induced smooth muscle relaxation occurred in rings with and without endothelium and in rings precontracted with increasing concentrations of phenylephrine, prostaglandin F2 alpha or KCI. Catalase (1000 U/ml) and mannitol (1 X 10(-3) M) did not block the neutrophil-induced relaxation, whereas phenazine methosulfate (1 X 10(- 5) M), hydroquinone (3 X 10(-5) M) and methylene blue (1 X 10(-5) M) reversed the neutrophil-induced relaxation. Pre-exposure of endothelium- rubbed rings to neutrophils (2 X 10(7) cells/organ chamber; 15 min) depressed the subsequent concentration-response curve to phenylephrine but augmented the relaxation induced by the phosphodiesterase inhibitor zaprinast (1 X 10(-5) M). The effluent from a column restraining the neutrophils induced a relaxation of endothelium-rubbed aortic rings that was prevented by methylene blue (1 X 10(-5) M). These results demonstrate that rat neutrophils release a factor that has a pharmacologic profile similar to that previously reported for the relaxing factor released from the vascular endothelium.
This article has been cited by other articles:
|
|
 |
|
  I. Berkestedt, A. Nelson, and M. Bodelsson Endogenous antimicrobial peptide LL-37 induces human vasodilatation Br. J. Anaesth., June 1, 2008; 100(6): 803 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Kerr, R. Yu, C. D. Stearns, N. A. Haynes, and R. J. Winquist Characterization of the Polymorphonuclear Leukocyte-Induced Vasoconstriction in Isolated Human Umbilical Veins J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 640 - 647. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. M. Tsoukias, Z. Tannous, A. F. Wilson, and S. C. George Single-exhalation profiles of NO and CO2 in humans: effect of dynamically changing flow rate J Appl Physiol, August 1, 1998; 85(2): 642 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. KRAUSE, M. R. MOODY, F. H. ANDRADE, A. A. TAYLOR, C. C. MILLER III, L. KOBZIK, and M. B. REID Peritonitis Causes Diaphragm Weakness in Rats Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1277 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. O. Zanardo, E. Costa, H. H. A. Ferreira, E. Antunes, A. R. Martins, F. Murad, and G. De Nucci Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils PNAS, December 9, 1997; 94(25): 14111 - 14114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Feder, D. Stelts, R. W. Chapman, D. Manfra, Y. Crawley, H. Jones, M. Minnicozzi, X. Fernandez, T. Paster, R. W. Egan, et al. Role of Nitric Oxide on Eosinophilic Lung Inflammation in Allergic Mice Am. J. Respir. Cell Mol. Biol., October 1, 1997; 17(4): 436 - 442. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. R. Hansen Role of Neutrophils in Myocardial Ischemia and Reperfusion Circulation, March 15, 1995; 91(6): 1872 - 1885. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
